Neuropeptide Y in trigeminal ganglion following chronic constriction injury of the rat infraorbital nerve: is there correlation to somatosensory parameters?

Pain ◽  
2001 ◽  
Vol 91 (1) ◽  
pp. 111-121 ◽  
Author(s):  
Rafael Benoliel ◽  
Eli Eliav ◽  
Michael J. Iadarola
Neuroreport ◽  
2017 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Yue Zhang ◽  
Dawei Zhu ◽  
Jilei Wang ◽  
Liangxin Yang ◽  
Liecheng Wang ◽  
...  

1987 ◽  
Vol 5 (1) ◽  
pp. 35-62 ◽  
Author(s):  
Robert W. Rhoades ◽  
Nicolas L. Chiaia ◽  
Richard D. Mooney ◽  
Bradley G. Klein ◽  
William E. Renehan ◽  
...  

2012 ◽  
Vol 2012 ◽  
pp. 1-8 ◽  
Author(s):  
Yoshizo Matsuka ◽  
Teruhiko Yokoyama ◽  
Yumiko Yamamoto ◽  
Tomonori Suzuki ◽  
Ni Nengah Dwi Fatmawati ◽  
...  

Type A neurotoxin (NTX) ofClostridium botulinumwas purified by a simple procedure using a lactose gel column. The toxicity of this purified toxin preparation was retained for at least 1 year at −30°C by supplementation with either 0.1% albumin or 0.05% albumin plus 1% trehalose. When purified NTX was used to treat 49 patients with urinary incontinence caused by either refractory idiopathic or neurogenic detrusor overactivity, 36 patients showed significant improvement in symptoms. These beneficial effects were also observed in cases of prostatic hyperplasia. The results obtained with NTX were similar to that of Botox. The effects of NTX on trigeminal neuralgia induced by infraorbital nerve constriction (IoNC) in rats were also studied. Trigeminal ganglion neurons from ipsilateral to IoNC exhibited significantly faster onset of FM4-64 release than sham-operated contralateral neurons. Intradermal injection of NTX in the area of IoNC alleviated IoNC-induced pain behavior and reduced the exaggerated FM4-64 release in trigeminal ganglion neurons.


2008 ◽  
Vol 172 (1) ◽  
pp. 43-47 ◽  
Author(s):  
Melanie Kernisant ◽  
Robert W. Gear ◽  
Luc Jasmin ◽  
Jean-Philippe Vit ◽  
Peter T. Ohara

Neuropeptides ◽  
2009 ◽  
Vol 43 (2) ◽  
pp. 133-142 ◽  
Author(s):  
Juliana G. Chichorro ◽  
Aleksander R. Zampronio ◽  
Daniela A. Cabrini ◽  
Celia R.C. Franco ◽  
Giles A. Rae

1993 ◽  
Vol 336 (2) ◽  
pp. 243-260 ◽  
Author(s):  
Theodore A. Henderson ◽  
Robert W. Rhoades ◽  
Carol A. Bennett-Clarke ◽  
Pat A. Osborne ◽  
Eugene M. Johnson ◽  
...  

2020 ◽  
Author(s):  
Lin-Xia Zhao ◽  
Xue-Qiang Bai ◽  
De-Li Cao ◽  
Xiao-Bo Wu ◽  
Ming Jiang ◽  
...  

Abstract Background: Trigeminal neuropathic pain (TNP) is a significant health problem whereas the involved mechanism has not been completely elucidated. Toll-like receptors (TLRs) are recently demonstrated to be expressed in the dorsal root ganglion and involved in chronic pain. How TLR8 is expressed in the trigeminal ganglion (TG) after infraorbital nerve injury and whether TLR8 is involved in TNP have not been investigated.Methods: TNP model was established by the partial infraorbital nerve ligation (pIONL) in mice. The effect of TLR8 and its agonist VTX-2337 on pain hypersensitivity was checked by facial pain behavioral test. The immunostaining, real-time RT-PCR, and western blot were used to evaluate the expression of TLR8, pERK, pp38, and proinflammatory cytokines in the TG. The intracellular concentration of Ca 2+ was detected by the calcium imaging.Results: TLR8 was persistently increased in TG neurons in pIONL-induced TNP model. In addition, deletion of Tlr8 or knockdown of Tlr8 in the TG attenuated pIONL-induced mechanical allodynia, reduced the activation of ERK and p38, and decreased the expression of proinflammatory cytokines in the TG. Furthermore, intra-TG injection of TLR8 agonist VTX-2337 induced facial pain hypersensitivity. VTX-2337 also increased intracellular calcium concentration, induced activation of ERK and p38, and increased the proinflammatory cytokines expression in the TG.Conclusions: TLR8 contributes to the maintenance of TNP through increasing MAPK-mediated neuroinflammation. Targeting TLR8 signaling may be effective for the treatment of TNP.


Sign in / Sign up

Export Citation Format

Share Document